Daniel Gray, Sherene Loi and Geoff Lindeman (IMAGE)

Walter and Eliza Hall Institute

Daniel Gray, Sherene Loi and Geoff Lindeman

Caption

Researchers have shown for the first time that combining two immunotherapy drugs could be effective in treating triple negative breast cancers arising in women with BRCA1 mutations.

Dr. Daniel Gray, Associate Professor Sherene Loi and Professor Geoff Lindeman (L-R) from the Walter and Eliza Hall Institute and Peter MacCallum Cancer Centre led the research.

Credit

Walter and Eliza Hall Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.